Sox9 is required for cartilage formation

Nature Genetics

Volumn 22, Issue 1, 1999, Pages 85-89

  Bi, Weimin ^a   Deng, Jian Min ^a   Zhang, Zhaoping ^a   Behringer, Richard R ^a   De Crombrugghe, Benoit ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ARTICLE; CARTILAGE; CHIMERA; CHONDROGENESIS; EMBRYO; EMBRYO DEVELOPMENT; ENHANCER REGION; GENE EXPRESSION; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEX TRANSFORMATION; SKELETON MALFORMATION; TERATOMA;

EID: 0345711458     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/8792     Document Type: Article

References (30)

1. Stockwell, R.A. in Biology of Cartilage Cells (Cambridge University Press, Cambridge, UK, 1979).
2. Hall, B. & Newman, S. in Cartilage: Molecular Aspects (CRC Press, Boca Raton, Florida, 1991).
3. Mundlos, S. & Olsen, B.R. Heritable diseases of the skeleton. Part I: molecular insights into skeletal development-transcription factors and signaling pathways. FASEB J. 11, 125-132 (1997).
4. Cancedda, R., Descalzi Cancedda, F. & Castagnola, P. Chondrocyte differentiation. Int. Rev. Cytol. 159, 265-358 (1995).
5. Erlebacher, A., Filvaroff, E.H., Gitelman, S.E. & Derynck, R. Toward a molecular understanding of skeletal development. Cell 80, 371-378 (1995).
6. Mundlos, S. & Olsen, B.R. Heritable diseases of the skeleton. Part II: molecular insights into skeletal development-matrix components and their homeostasis. FASEB J. 11, 227-233 (1997).
7. Wagner, T. et al. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79, 1111-1120 (1994).
8. Wright, E. et al. The Sry-related gene Sox-9 is expressed during chrondrogenesis in mouse embryos. Nature Genet. 9, 15-20 (1995).
9. Kent, J., Wheatley, S.C., Andrews, J.E., Sinclair, A.H. & Koopman, P. A male-specific role for SOX9 in vertebrate sex determination. Development 122, 2813-2822 (1996).
10. Morais da Silva, S. et al. Sox9 expression during gonadal development implies a conserved role for the gene in testis differentiation in mammals and birds. Nature Genet. 14, 62-68 (1996).
11. Ng, L.-J. et al. Sox9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Dev. Biol. 183, 108-121 (1997).
12. Zhao, Q., Eberspaecher, H., Lefebvre, V. & de Crombrugghe, B. Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis. Dev. Dyn. 209, 377-386 (1997).
13. Hovmoller, M.L. et al. Campomelic dwarfism. A genetically determined mesenchymal disorder combined with sex reversal. Hereditas 86, 51-62 (1977).
14. Takahashi, H., Sando, I. & Masutani, H. Temporal bone histopathological findings in campomelic dysplasia. J. Laryngol. Otol. 106, 361-365 (1992).
15. Foster, J.W. et al. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372, 525-530 (1994).
16. Kwok, C. et al. Mutations in SOX9, the gene responsible for campomelic dysplasia and autosomal sex reversal. Am. J. Hum. Genet. 57, 1028-1036 (1995).
17. Bell, D.M. et al. Sox9 directly regulates the type-II collagen gene. Nature Genet. 16, 174-178 (1997).
18. Lefebvre, V., Huang, W., Harley, V.R., Goodfellow, P.N. & de Crombrugghe, B. SOX9 is a potent activator of the chondrocyte-specific enhancer of the proα1(II) collagen gene. Mol. Cell. Biol. 17, 2336-2346 (1997).
19. Bridgewater, L.C., Lefebvre, V. & de Crombrugghe, B. Chondrocyte-specific enhancer elements in the Col11a2 gene resemble the Col2a1 tissue-specific enhancer. J. Biol. Chem. 273, 14998-15006 (1998).
20. Widelitz, R.B., Jiang, T.X., Murray, B.A. & Chuong, C.M. Adhesion molecules in skeletogenesis: II. Neural cell adhesion molecules mediate precartilaginous mesenchymal condensations and enhance chondrogenesis. J. Cell Physiol. 156, 399-411 (1993).
21. Oberlender, S.A. & Tuan, R.S. Expression and functional involvement of N-cadherin in embryonic limb chondrogenesis. Development 120, 177-187 (1994).
22. Mountford, P. et al. Dicistronic targeting constructs: reporters and modifiers of mammalian gene expression. Proc. Natl Acad. Sci. USA 91, 4303-4307 (1994).
23. Behringer, R.R., Finegold, M.J. & Cate, R.L. Müllerian-inhibiting substance function during mammalian sexual development. Cell 79, 415-425 (1994).
24. Abuin, A. & Bradley, A. Recycling selectable markers in mouse embryonic stem cells. Mol. Cell. Biol. 16, 1851-1856 (1996).
25. Hogan, B., Beddington, R., Costantini, F. & Lacy, E. in Manipulating the Mouse Embryo: A Laboratory Manual (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1994).
26. Wilkinson, D.G. & Nieto, M.A. Detection of messenger RNA by in situ hybridization to tissue sections and whole-mounts. Methods Enzymol. 225, 361-373 (1993).
27. Metsäranta, M., Toman, D., de Crombrugghe, B. & Vuorio, E. Specific hybridization probes for mouse type I, II, III and IX collagen mRNAs. Biochim. Biophys. Acta 1089, 241-243 (1991).
28. Glumoff, V., Savontaus, M., Vehanen, J. & Vuorio, E. Analysis of aggrecan and tenascin gene expression in mouse skeletal tissues by northern and in situ hybridization using species specific cDNA probes. Biochim. Biophys. Acta 1219, 613-622 (1994).
29. Elima, K. et al. Specific hybridization probes for mouse α2(IX) and α1(X) collagen mRNAs. Biochim. Biophys. Acta 1130, 78-80 (1992).
30. Robertson, E.J. in Teratocarcinomas and Embryonic Stem Cells: A Practical Approach (IRL Press, Oxford, UK, 1987).